KMT2A and leukemia: These infant leukemias are often driven by chromosomal translocations of the KMT2A gene with AFF1 (t(4;11)), and the resulting KMT2A::AFF1 oncogene (MLL::AF4) gives rise to an aggressive, poor prognosis B cell leukemia [1–4].